CY2399B1 - Pharmaceutical composition containing cyclosporin derivative. - Google Patents

Pharmaceutical composition containing cyclosporin derivative.

Info

Publication number
CY2399B1
CY2399B1 CY0300096A CY0300096A CY2399B1 CY 2399 B1 CY2399 B1 CY 2399B1 CY 0300096 A CY0300096 A CY 0300096A CY 0300096 A CY0300096 A CY 0300096A CY 2399 B1 CY2399 B1 CY 2399B1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical composition
composition containing
containing cyclosporin
cyclosporin derivative
composition
Prior art date
Application number
CY0300096A
Other languages
English (en)
Inventor
Armin Meinzer
Friedrich Richter
Jacky Francis Vonderscher
Original Assignee
Sandoz Ltd
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd, Sandoz Ag filed Critical Sandoz Ltd
Publication of CY2399B1 publication Critical patent/CY2399B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CY0300096A 1992-04-22 2003-12-31 Pharmaceutical composition containing cyclosporin derivative. CY2399B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208712A GB9208712D0 (en) 1992-04-22 1992-04-22 Pharmaceutical compositions containing cyclosporin derivates

Publications (1)

Publication Number Publication Date
CY2399B1 true CY2399B1 (en) 2004-09-10

Family

ID=10714386

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300096A CY2399B1 (en) 1992-04-22 2003-12-31 Pharmaceutical composition containing cyclosporin derivative.

Country Status (22)

Country Link
EP (1) EP0637248B1 (xx)
JP (1) JP2818298B2 (xx)
KR (2) KR950701227A (xx)
AT (1) ATE219940T1 (xx)
AU (1) AU672793B2 (xx)
CA (1) CA2132740C (xx)
CY (1) CY2399B1 (xx)
CZ (1) CZ287359B6 (xx)
DE (1) DE69332078T2 (xx)
DK (1) DK0637248T3 (xx)
ES (1) ES2179052T3 (xx)
FI (1) FI111130B (xx)
GB (1) GB9208712D0 (xx)
HU (1) HU218279B (xx)
NO (1) NO315075B1 (xx)
NZ (1) NZ252681A (xx)
PT (1) PT637248E (xx)
RU (1) RU2126263C1 (xx)
SG (1) SG50692A1 (xx)
SK (1) SK282745B6 (xx)
UA (1) UA34454C2 (xx)
WO (1) WO1993020833A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
DK0642332T3 (da) 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
KR970704464A (ko) 1994-11-03 1997-09-06 가이슐러 에리히, 데커 카를-루드빅 간단한 조성 및 높은 생물 유효성을 갖는 경구 투여용의 신규 사이클로스포린 제형 및 이의 제조방법(Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them)
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
NZ502566A (en) * 1997-07-29 2002-03-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation containing a pyranone and a basic amine
CA2294031E (en) * 1997-07-29 2012-04-03 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
JP2005500314A (ja) 2001-06-21 2005-01-06 ファイザー・プロダクツ・インク コレステロールエステル転送蛋白インヒビターの自己乳化性製剤
US6828301B2 (en) 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
EP2204167A1 (en) * 2009-01-05 2010-07-07 Azad Pharma AG Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
DK2451438T3 (da) 2009-07-07 2014-03-10 Boehringer Ingelheim Int Farmaceutisk sammensætning til en hepatitis C-virus-roteaseinhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins

Also Published As

Publication number Publication date
EP0637248B1 (en) 2002-07-03
FI944978A (fi) 1994-10-21
NO315075B1 (no) 2003-07-07
DE69332078T2 (de) 2002-12-19
PT637248E (pt) 2002-11-29
SG50692A1 (en) 1999-05-25
DE69332078D1 (de) 2002-08-08
DK0637248T3 (da) 2002-10-28
ES2179052T3 (es) 2003-01-16
UA34454C2 (uk) 2001-03-15
GB9208712D0 (en) 1992-06-10
HUT71580A (en) 1995-12-28
NO943998D0 (no) 1994-10-21
CA2132740A1 (en) 1993-10-28
AU672793B2 (en) 1996-10-17
FI111130B (fi) 2003-06-13
HU218279B (en) 2000-07-28
NO943998L (no) 1994-10-21
CZ287359B6 (en) 2000-11-15
SK282745B6 (sk) 2002-12-03
RU94046413A (ru) 1996-11-10
JP2818298B2 (ja) 1998-10-30
RU2126263C1 (ru) 1999-02-20
EP0637248A1 (en) 1995-02-08
KR100414853B1 (xx) 2004-01-13
HU9403055D0 (en) 1994-12-28
CZ261794A3 (en) 1995-02-15
SK127294A3 (en) 1995-04-12
KR950701227A (ko) 1995-03-23
AU4261193A (en) 1993-11-18
CA2132740C (en) 2008-01-15
NZ252681A (en) 1996-02-27
FI944978A0 (fi) 1994-10-21
WO1993020833A1 (en) 1993-10-28
ATE219940T1 (de) 2002-07-15
JPH07505872A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
SG50692A1 (en) Pharmaceutical composition containing cyclosporin derivative
ES2098180A1 (es) Una composicion farmaceutica a base de compuestos de la clase de la rapamicina.
CA2189351A1 (en) Narcotic containing aerosol formulation
AU1226492A (en) Optically active 5h-pyrrolo(3,4-b)pyrazine derivative, its preparation and pharmaceutical compositions containing same
HUT75470A (en) Lipophilic carrier preparations
EP0573423A4 (en) Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
AU629669B2 (en) Diarylacetylenes, the preparations and use thereof
MX9204379A (es) Microemulsiones de agua en aceite auto-emulsificables, estables, farmaceuticamente aceptables.
CA2178632A1 (en) Pharmaceutical compositions containing hiv protease inhibitors
DE69700317T2 (de) Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol
CA2067754A1 (en) Preparation for the application of agents in mini-droplets
UA40634C2 (uk) Мікрокапсула, яка містить суспензію твердої біологічно активної сполуки, і спосіб її одержання
YU3700A (sh) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
IL105942A0 (en) Biologically active eburnamenine derivatives,their preparation and pharmaceutical compositions containing them
AU7588094A (en) Dihalopropene compound, insecticide/acaricide containing said diahalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound
KR950007857A (ko) 경구투여용 라파마이신 제제
AU4482489A (en) Novel tetrahydropyrimidine derivatives, process for their preparation and insecticides containing same as active ingredients
NZ237739A (en) Pharmaceutical composition of a complement inhibitor and an immunosuppressant with cyclosporin a-like activity, and its use
IL93548A0 (en) Ws7622a,b,c and d substances,derivatives thereof,processes for the preparation thereof and pharmaceutical compositions containing the same
PL307238A1 (en) Derivatives of ng-monomethyl-l-arginin hydrochloride and their application in treating septic shocks
AU4132693A (en) Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
KR890015674A (ko) 수면 시용 농약 입제
AU8079891A (en) Bile alcohol and drug containing the same as active ingredient
AU2309288A (en) Oxime derivatives and herbicides containing same as active ingredients
AU4965493A (en) Optically active ureido-acetamide derivative, its preparation and drugs containing same